Merck & Co. Inc. (MRK)

$ 99.86
   
  • Change Today:
    $2.42
  • 52 Week High: $132.96
  • 52 Week Low: $96.31
  • Currency: US Dollars
  • Shares Issued: 2,531.63m
  • Volume: 15,631,800
  • Market Cap: $252,809m
  • RiskGrade: 92
  • Beta: 0.19

Latest ShareCast News

Merck tops Q3 earnings forecasts despite slower Gardasil demand

By Josh White

Date: Thursday 31 Oct 2024

(Sharecast News) - Pharmaceuticals firm Merck reported a solid third quarter on Thursday, with revenue up 4% year-over-year to $16.7bn, driven by robust sales of its cancer drug Keytruda, although muted demand for the Gardasil HPV vaccine remained a challenge.

Merck News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Merck Market Data

Currency US Dollars
Share Price $ 99.86
Change Today $ 2.42
% Change 2.48 %
52 Week High $132.96
52 Week Low $96.31
Volume 15,631,800
Shares Issued 2,531.63m
Market Cap $252,809m
Beta 0.19
RiskGrade 92

What The Brokers Say

Strong Buy 10
Buy 11
Neutral 4
Sell 0
Strong Sell 0
Total 25
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 21-Nov-2024

Time Volume / Share Price
15:59 100 @ $99.89
15:59 100 @ $99.88
15:59 184 @ $99.98
15:59 100 @ $99.98
15:59 184 @ $99.98

Top of Page